Graniforce -MD Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Granisetron (1mg)
Overview Graniforce -MD Tablet
Graniforce-MD tablets offer relief from nausea and vomiting stemming from surgery, chemotherapy, or radiation therapy. However, this antiemetic medication does not address other cancer treatment side effects and is ineffective against motion sickness. Always adhere to your physician's prescribed dosage and schedule; consistent timing is recommended. Discontinue use only under your doctor's guidance. If vomiting occurs within an hour of ingestion, repeat the dose and avoid large meals that day. Common side effects include headache, constipation, diarrhea, and fatigue. Dizziness and drowsiness are also possible; refrain from driving or mentally demanding tasks until the effects are known. These typically subside upon cessation, but persistent or bothersome symptoms warrant consultation with your doctor for management strategies. Prior to commencing treatment, inform your doctor of any existing heart or liver conditions, intestinal obstructions, or concurrent medications, particularly those for epilepsy, cardiac issues, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should seek medical counsel before use.
Primary Ingredients of Graniforce -MD Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Graniforce -MD Tablet
Chemotherapy-induced emesis
Major Benefits of Graniforce -MD Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for Graniforce-MD Tablets. Always dissolve the tablet in water before consumption. While Graniforce-MD Tablets can be ingested with or without food, consistent daily timing is recommended.
Common Side effects of Graniforce -MD Tablet:
- Weakness
- Headache
- Constipation
- Diarrhea
- Insomnia (difficulty in sleeping)
How to use Graniforce -MD Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Graniforce-MD Tablets. Always dissolve the tablet in water before consumption. While Graniforce-MD Tablets can be ingested with or without food, consistent timing is recommended for optimal results.
How Graniforce -MD Tablet works:
Graniforce-MD tablets offer antiemetic relief. This medication functions by inhibiting the activity of serotonin, a neurotransmitter in the brain, which can trigger nausea and vomiting associated with chemotherapy or post-surgical recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Graniforce-MD Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Graniforce-MD Tablets are typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The medication Graniforce-MD Tablet is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Graniforce-MD Tablets.
KidneySAFE IF PRESCRIBED
Graniforce-MD Tablets appear to pose minimal risk for individuals with kidney disease. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Graniforce-MD Tablets appear to be well-tolerated by individuals with hepatic impairment. Current evidence indicates dose modification may not be necessary, but physician consultation is recommended.
What if you forget to take Graniforce -MD Tablet :
Should you forget a Graniforce-MD Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Graniforce -MD Tablet
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | 5-HT3 receptor blockers |






